...
首页> 外文期刊>Saudi Pharmaceutical Journal >Evaluation of microalgae and cyanobacteria as potential sources of antimicrobial compounds
【24h】

Evaluation of microalgae and cyanobacteria as potential sources of antimicrobial compounds

机译:微藻和青霉菌评估作为抗微生物化合物的潜在来源

获取原文

摘要

In recent decades, marine microorganisms have become known for their ability to produce a wide variety of secondary bioactive metabolites. Several compounds have been isolated from marine microorganisms for the development of novel bioactives for the food and pharmaceutical industries. In this study, a number of microalgae were evaluated for their antimicrobial activity against gram-positive and gram-negative bacteria, including food and plant pathogens, using various extraction techniques and antimicrobial assays. Disc diffusion and spot-on-lawn assays were conducted to confirm the antimicrobial activity. To measure the potency of the extracts, minimum inhibition concentrations (MIultCs) were measured. Three microalgae, namely Isochrysis galbana , Scenedesmus sp. NT8c, and Chlorella sp. FN1, showed strong inhibitory activity preferentially against gram-positive bacteria. These microalgal species were then selected for further purification and analysis, leading to compound identification. By using a mixture of different chromatography techniques gas chromatography–mass spectrometry (GC–MS) and high-performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS), we were able to separate and identify the dominant compounds that are responsible for the inhibitory activity. Additionally, nuclear magnetic resonance (NMR) was used to confirm the presence of these compounds. The dominant compounds that were identified and purified in the extracts are linoleic acid, oleic acid, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). These compounds are the potential candidates that inhibit the growth of gram-positive bacteria. This indicates the potential use of microalgae and their antimicrobial compounds as biocontrol agents against food and plant pathogens.
机译:近几十年来,海洋微生物已知其产生各种次级生物活性代谢物的能力。几种化合物已从海洋微生物中分离出用于开发食品和制药行业的新型生物术。在这项研究中,使用各种提取技术和抗微生物测定评估了对革兰氏阳性和革兰氏阴性细菌的抗微生物的抗菌活性,用于使用各种提取技术和抗微生物测定。进行盘扩散和斑点对草坪测定以确认抗微生物活性。为了测量提取物的效力,测量最小抑制浓度(MIULTC)。三个微藻,即isochrysis galbana,scenedesmus sp。 NT8C和小球藻SP。 FN1,优先针对革兰氏阳性细菌的强抑制活性。然后选择这些微藻物种以进一步纯化和分析,导致复合鉴定。通过使用不同色谱技术的混合物气相色谱 - 质谱(GC-MS)和高性能液相色谱(HPLC)和超高效液相色谱 - 四极其飞行时间质谱(UHPLC-Q-TOF- MS),我们能够分离并识别负责抑制活性的主要化合物。另外,使用核磁共振(NMR)来确认这些化合物的存在。在提取物中鉴定和纯化的主要化合物是亚油酸,油酸,二十二糖六烯酸(DHA)和eicosapentaeno酸(EPA)。这些化合物是抑制革兰氏阳性细菌生长的潜在候选者。这表明微藻和其抗菌化合物作为对食物和植物病原体的生物控制剂的潜在用途。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号